News

With that in mind, let's consider two stocks down 17% and 36%, respectively, this year that are worth investing in right now: ...
The U.S. FDA is asking Novavax (NASDAQ:NVAX) to conduct an additional randomized, controlled study of its COVID-19 vaccine ...
The US Food and Drug Administration has discussed with vaccine-maker Novavax the need for an additional trial of its Covid-19 ...
If found to be lacking adequate compliance systems, Moderna could ultimately be suspended or expelled from the Association of ...
Federal regulators are asking Novavax to complete an additional randomized clinical trial on its Covid-19 vaccine after ...